Alessio Cortellini, Assistant Professor at Campus Bio-Medico University of Rome, shared a post on X by Valentina Santo, Research fellow in Thoracic Oncology at Dana-Farber Cancer Institute, adding:
“Proud of our own Leonardo Brunetti.
Post-hoc analysis of PACIFIC detrimental effect of baseline PPIs/ATB restricted to patients receiving durva, no impact on placebo.”
Quoting Valentina Santo’s post below:
“Go check Leonardo Brunetti presenting the first results of our post-hoc analysis of the PACIFIC Trial on the differential impact of PPIs and antibiotics on clinical outcomes from IO, led by him and Alessio Cortellini.”